Simulation-based Bayesian predictive probability of success for interim monitoring of clinical trials with competing event data: two case studies

Fuente: arXiv
Salvato in:
Dettagli Bibliografici
Autori principali: Micoli, Chiara, Crippa, Alessio, Connor, Jason T., Consortium, I-SPY COVID, Eklund, Martin, Discacciati, Andrea
Natura: Preprint
Pubblicazione: 2024
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1866916535949328384
author Micoli, Chiara
Crippa, Alessio
Connor, Jason T.
Consortium, I-SPY COVID
Eklund, Martin
Discacciati, Andrea
author_facet Micoli, Chiara
Crippa, Alessio
Connor, Jason T.
Consortium, I-SPY COVID
Eklund, Martin
Discacciati, Andrea
contents Bayesian predictive probabilities of success (PPoS) use interim trial data to calculate the probability of trial success. These quantities can be used to optimize trial size or to stop for futility. In this paper, we describe a simulation-based approach to compute the PPoS for clinical trials with competing event data, for which no specific methodology is currently available. The proposed procedure hinges on modelling the joint distribution of time to event and event type by specifying Bayesian models for the cause-specific hazards of all event types. This allows the prediction of outcome data at the conclusion of the trial. The PPoS is obtained by numerically averaging the probability of success evaluated at fixed parameter values over the posterior distribution of the parameters. Our work is motivated by two randomised clinical trials: the I-SPY COVID phase II trial for the treatment of severe COVID-19 (NCT04488081) and the STHLM3 prostate cancer diagnostic trial (ISRCTN84445406), both of which are characterised by competing event data. We present different modelling alternatives for the joint distribution of time to event and event type and show how the choice of the prior distributions can be used to assess the PPoS under different scenarios. The role of the PPoS analyses in the decision making process for these two trials is also discussed.
format Preprint
id arxiv_https___arxiv_org_abs_2412_15899
institution arXiv
publishDate 2024
record_format arxiv
spellingShingle Simulation-based Bayesian predictive probability of success for interim monitoring of clinical trials with competing event data: two case studies
Micoli, Chiara
Crippa, Alessio
Connor, Jason T.
Consortium, I-SPY COVID
Eklund, Martin
Discacciati, Andrea
Methodology
Applications
Bayesian predictive probabilities of success (PPoS) use interim trial data to calculate the probability of trial success. These quantities can be used to optimize trial size or to stop for futility. In this paper, we describe a simulation-based approach to compute the PPoS for clinical trials with competing event data, for which no specific methodology is currently available. The proposed procedure hinges on modelling the joint distribution of time to event and event type by specifying Bayesian models for the cause-specific hazards of all event types. This allows the prediction of outcome data at the conclusion of the trial. The PPoS is obtained by numerically averaging the probability of success evaluated at fixed parameter values over the posterior distribution of the parameters. Our work is motivated by two randomised clinical trials: the I-SPY COVID phase II trial for the treatment of severe COVID-19 (NCT04488081) and the STHLM3 prostate cancer diagnostic trial (ISRCTN84445406), both of which are characterised by competing event data. We present different modelling alternatives for the joint distribution of time to event and event type and show how the choice of the prior distributions can be used to assess the PPoS under different scenarios. The role of the PPoS analyses in the decision making process for these two trials is also discussed.
title Simulation-based Bayesian predictive probability of success for interim monitoring of clinical trials with competing event data: two case studies
topic Methodology
Applications
url https://arxiv.org/abs/2412.15899